Keymed Biosciences Inc. (HKG:2162)
57.50
+1.60 (2.86%)
Jun 18, 2026, 4:08 PM HKT
Keymed Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $89.47 | Buy | Maintains | $89.47 | +55.60% | May 28, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $97.00 | Buy | Maintains | $97.00 | +68.70% | May 28, 2026 |
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $87.31 | Buy | Maintains | $87.31 | +51.84% | Apr 4, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $91.08 → $91.13 | Buy | Maintains | $91.08 → $91.13 | +58.49% | Mar 30, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $78.00 | Buy | Maintains | $78.00 | +35.65% | Mar 24, 2026 |
Unknown Analyst Sinolink Securities No rating | Sinolink Securities | Buy Maintains $83.29 | Buy | Maintains | $83.29 | +44.85% | Dec 26, 2025 |